Full metadata record

DC Field Value Language
dc.contributor.authorKim, Soon-Hee-
dc.contributor.authorSeo, Misun-
dc.contributor.authorHwang, Hongik-
dc.contributor.authorMoon, Dong-Min-
dc.contributor.authorSon, Gi Hoon-
dc.contributor.authorKim, Kyungjin-
dc.contributor.authorRhim, Hyewhon-
dc.date.accessioned2024-01-19T21:01:00Z-
dc.date.available2024-01-19T21:01:00Z-
dc.date.created2021-09-02-
dc.date.issued2019-02-
dc.identifier.issn1226-2560-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/120402-
dc.description.abstract5-HT6 receptor (5-HT6R) is implicated in cognitive dysfunction, mood disorder, psychosis, and eating disorders. However, despite its significant role in regulating the brain functions, regulation of 5-HT6R at the molecular level is poorly understood. Here, using yeast two-hybrid assay, we found that human 5-HT6R directly binds to neuro-oncological ventral antigen 1 (Nova-1), a brain-enriched splicing regulator. The interaction between 5-HT6R and Nova-1 was confirmed using GST pull-down and co-immunoprecipitation assays in cell lines and rat brain. The splicing activity of Nova-1 was decreased upon overexpression of 5-HT6R, which was examined by detecting the spliced intermediates of gonadotropin-releasing hormone (GnRH), a known pre-mRNA target of Nova-1, using RT-PCR. In addition, overexpression of 5-HT6R induced the translocation of Nova-1 from the nucleus to cytoplasm, resulting in the reduced splicing activity of Nova-1. In contrast, overexpression of Nova-1 reduced the activity and the total protein levels of 5-HT6R. Taken together, these results indicate that when the expression levels of 5-HT6R or Nova-1 protein are not properly regulated, it may also deteriorate the function of the other.-
dc.languageEnglish-
dc.publisherKOREAN SOC BRAIN & NEURAL SCIENCE, KOREAN SOC NEURODEGENERATIVE DISEASE-
dc.titlePhysical and Functional Interaction between 5-HT6 Receptor and Nova-1-
dc.typeArticle-
dc.identifier.doi10.5607/en.2019.28.1.17-
dc.description.journalClass1-
dc.identifier.bibliographicCitationExperimental Neurobiology, v.28, no.1, pp.17 - 29-
dc.citation.titleExperimental Neurobiology-
dc.citation.volume28-
dc.citation.number1-
dc.citation.startPage17-
dc.citation.endPage29-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
dc.identifier.kciidART002444277-
dc.identifier.wosid000460388900002-
dc.identifier.scopusid2-s2.0-85067888899-
dc.relation.journalWebOfScienceCategoryMedicine, Research & Experimental-
dc.relation.journalWebOfScienceCategoryNeurosciences-
dc.relation.journalResearchAreaResearch & Experimental Medicine-
dc.relation.journalResearchAreaNeurosciences & Neurology-
dc.type.docTypeArticle-
dc.subject.keywordPlusINHIBITION-
dc.subject.keywordPlusSB-399885-
dc.subject.keywordPlusANTIGEN-
dc.subject.keywordPlusRNA-BINDING PROTEINS-
dc.subject.keywordPlusANTAGONIST-
dc.subject.keywordPlusDISEASE-
dc.subject.keywordPlusMODELS-
dc.subject.keywordPlusANTIDEPRESSANT-
dc.subject.keywordPlusLOCALIZATION-
dc.subject.keywordPlusRECOGNITION-
dc.subject.keywordAuthorSerotonin-
dc.subject.keywordAuthor5-HT6 receptor-
dc.subject.keywordAuthorNeuro-oncological ventral antigen 1-
dc.subject.keywordAuthorRNA binding proteins-
dc.subject.keywordAuthorNeurological diseases-
Appears in Collections:
KIST Article > 2019
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE